Home > Press > Medtech Insight and Windhover Information Announce Their Upcoming ``Investment In Innovation (In3) Europe'' Early- to Late-Stage Medical Technology In
Abstract:
April 29-30, 2008, Paris, France, The Hilton Paris
Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, will host the upcoming "Investment In Innovation (In3) Europe" conference April 29-30, 2008 at The Hilton Paris Hotel in Paris, France. In3 Europe - the company's 30th In3 conference - will showcase over 30 highly promising start-up med device companies from around the world presenting to an audience of senior business development and investment executives from the leading medical technology and healthcare investment firms worldwide, for purposes of raising funding or forming strategic partnerships. Event details will be posted regularly on the In3 Europe website, at www.windhover.com/in3europe08.
Presentations from a carefully selected group of cutting-edge, early- to late-stage companies will encompass a wide variety of high-growth device sectors, including cardiovascular therapeutics and diagnostics/interventional cardiology, diagnostics, drug delivery, imaging, minimally invasive surgery, nanotechnology, neurostimulation, oncology, orthopedics/spine, peripheral vascular, stem cells, stroke management, tissue engineering, and wound management, to mention only a few.
The In3 Europe format will include focused 10-minute presentations by a senior executive from each presenting company to our full audience, each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The event will also feature plenary sessions by device industry thought leaders, informative and interactive panel discussions covering a variety of topics impacting medical device innovation and investment in the U.S., Europe, and other regions, a presenting company product exhibition/networking reception, and educational workshops.
Medtech Insight and its parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1350 emerging medical technology company presenters and over 7200 attendees have participated at In3 events over the past 7 years.
In3 Europe is a must-attend event for anyone interested in emerging medical technology impacting the worldwide med device market. To register to attend, or if your company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., or register on the Medtech Insight website at www.windhover.com/in3europe08. The early bird attendee registration rate of $1295 ($400 off the regular rate) expires February 16, 2008.
Medtech Insight and Windhover Information will also be holding their "Investment In Innovation (In3) Summit" conference in San Francisco, CA, June 17-19, featuring over 50 medtech company presentations in 3 concurrent specialty tracks, as well as their "In3 East" conference in Boston, MA, October 22-24. For more information on these upcoming events, please call Medtech Insight or visit the company's website at www.medtechinsight.com.
####
About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace.
For more information, please click here
Contacts:
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes
480-985-9512
or 888-202-5939 toll-free in the U.S.
www.medtechinsight.com
www.windhover.com
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
New method in the fight against forever chemicals September 13th, 2024
Energy transmission in quantum field theory requires information September 13th, 2024
Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Announcements
New discovery aims to improve the design of microelectronic devices September 13th, 2024
New method in the fight against forever chemicals September 13th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||